We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$304M
AUM Growth
+$23.3M
Cap. Flow
+$22.5M
Cap. Flow %
7.38%
Top 10 Hldgs %
36.29%
Holding
363
New
24
Increased
32
Reduced
61
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISF.CL
201
DELISTED
ING Groep NV
ISF.CL
$26K 0.01%
+1,000
New +$25.9K
LLY icon
202
Eli Lilly
LLY
$1.05T
$25K 0.01%
300
SDY icon
203
State Street SPDR S&P Dividend ETF
SDY
$22B
$25K 0.01%
280
GSK icon
204
GSK
GSK
$102B
$24K 0.01%
440
NSC icon
205
Norfolk Southern
NSC
$78.3B
$24K 0.01%
200
PNC icon
206
PNC Financial Services
PNC
$96.6B
$23K 0.01%
188
WMT icon
207
Walmart Inc
WMT
$820B
$23K 0.01%
900
COST icon
208
Costco
COST
$419B
$22K 0.01%
140
JCI icon
209
Johnson Controls International
JCI
$84.6B
$22K 0.01%
501
UNP icon
210
Union Pacific
UNP
$183B
$22K 0.01%
200
MCHP icon
211
Microchip Technology
MCHP
$39.6B
$21K 0.01%
538
MPC icon
212
Marathon Petroleum
MPC
$104B
$21K 0.01%
400
BDX icon
213
Becton Dickinson
BDX
$51.6B
$20K 0.01%
104
CALM icon
214
Cal-Maine
CALM
$3.75B
$20K 0.01%
500
HSBC.PRA
215
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$20K 0.01%
+750
New +$19.6K
TXT icon
216
Textron
TXT
$14.3B
$19K 0.01%
400
BIDU icon
217
Baidu
BIDU
$32.9B
$18K 0.01%
100
KLAC icon
218
KLA
KLAC
$229B
$18K 0.01%
2,000
NOC icon
219
Northrop Grumman
NOC
$77.5B
$18K 0.01%
70
CMD
220
DELISTED
Cantel Medical Corporation
CMD
$18K 0.01%
230
CC icon
221
Chemours
CC
$2.35B
$17K 0.01%
436
FDS icon
222
Factset
FDS
$11B
$17K 0.01%
100
GLNG icon
223
Golar LNG
GLNG
$5.13B
$17K 0.01%
750
ROX
224
DELISTED
Castle Brands, Inc.
ROX
$17K 0.01%
10,000
FMAT icon
225
Fidelity MSCI Materials Index ETF
FMAT
$622M
$16K 0.01%
500

Similar funds

American Research & Management Company's Q2 2017 Portfolio in Review

As of Q2 2017, American Research & Management Company held 363 positions worth $304M, up 8.3% from $281M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

American Research & Management Company deployed $22.5M of net new capital in Q2 2017, opening 24 new positions and adding to 32 existing holdings. Its largest new stake was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was IBM, an estimated $868K trimmed.

  • American Research & Management Company's largest Q2 2017 buy was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.
  • American Research & Management Company added most to State Street SPDR ICE Preferred Securities ETF in Q2 2017, an estimated $5.38M increase.
  • American Research & Management Company's biggest Q2 2017 reduction was IBM, cutting an estimated $868K.
  • American Research & Management Company fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $249K.
  • American Research & Management Company's ten largest holdings make up 36% of its $304M portfolio in Q2 2017.
  • American Research & Management Company opened 24 new positions and closed 17 in Q2 2017.
  • American Research & Management Company's portfolio value rose 8.3% quarter-over-quarter to $304M.

Based on American Research & Management Company's 13F filing for Q2 2017, filed 27 Jul 2017.